BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19362667)

  • 1. Are new drugs for schizophrenia better than old ones?
    Gøtzsche P
    Lancet; 2009 Apr; 373(9671):1248; author reply 1249-50. PubMed ID: 19362667
    [No Abstract]   [Full Text] [Related]  

  • 2. Are new drugs for schizophrenia better than old ones?
    Anghelescu I; Dettling M
    Lancet; 2009 Apr; 373(9671):1249; author reply 1249-50. PubMed ID: 19362668
    [No Abstract]   [Full Text] [Related]  

  • 3. Are new drugs for schizophrenia better than old ones?
    Jauhar S;
    Lancet; 2009 Apr; 373(9671):1249; author reply 1249-50. PubMed ID: 19362669
    [No Abstract]   [Full Text] [Related]  

  • 4. New generation versus conventional antipsychotics.
    Geddes J; Harrison P; Freemantle N
    Lancet; 2003 Aug; 362(9381):404; author reply 404-5. PubMed ID: 12907021
    [No Abstract]   [Full Text] [Related]  

  • 5. First- vs second-generation antipsychotic drugs in schizophrenia.
    Andrade C; Kharawala S
    Arch Gen Psychiatry; 2007 Aug; 64(8):978-9; author reply 979-80. PubMed ID: 17679643
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of schizophrenia drugs often favors firm funding study.
    Vendantam S
    Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276
    [No Abstract]   [Full Text] [Related]  

  • 7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.
    Tandon R; Nasrallah HA
    Arch Gen Psychiatry; 2006 Aug; 63(8):935-7; author reply 937-9. PubMed ID: 16894070
    [No Abstract]   [Full Text] [Related]  

  • 9. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CATIE study.
    Teich J
    Am J Psychiatry; 2006 Mar; 163(3):554-5; author reply 555-6. PubMed ID: 16513894
    [No Abstract]   [Full Text] [Related]  

  • 11. [Priority for atypical antipsychotic drugs? Current studies clarify the issues].
    Dose M
    Psychiatr Prax; 2007 Jan; 34(1):46-9. PubMed ID: 17265252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antipsychotic agents: what do meta analyses say?].
    Millet B
    Encephale; 2007 Jun; 33 Pt 3():S419-24. PubMed ID: 19101363
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
    Fleischhacker WW; Widschwendter CG
    Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poker ala the "mega" studies].
    Kálmán J
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):261-2. PubMed ID: 19419010
    [No Abstract]   [Full Text] [Related]  

  • 15. The CATIE study.
    Basil B; Mathews M; Adetunji B; Budur K
    Am J Psychiatry; 2006 Mar; 163(3):555; author reply 555-6. PubMed ID: 16513895
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 18. CUtLASS confirms CATIE.
    Mintz J; Kopelowicz A
    Arch Gen Psychiatry; 2007 Aug; 64(8):978; author reply 979-80. PubMed ID: 17679644
    [No Abstract]   [Full Text] [Related]  

  • 19. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of first-episode schizophrenia.
    Rosenheck RA
    Lancet; 2008 Mar; 371(9618):1048-9. PubMed ID: 18374824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.